Effect of Intravenous Tranexamic Acid on Blood Loss Reduction During and After Caesarean Section: A Randomized Controlled Study

Effect of Intravenous Tranexamic Acid on Blood Loss Reduction During and After Caesarean Section: A Randomized Controlled Study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202406748563034

Enrollment

Registered

2024-06-26

Start date

2023-06-30

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Intravenous Tranexamic Acid

Water for injection

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All women who consented for elective Caesarean section and also consented for the study without the exclusion criteria.

Exclusion criteria

Exclusion criteria: Women with known coagulation disorders Women on anticoagulant Women allergic to tranexamic acid Women with history of thromboembolism Women with preeclampsia, eclampsia, sickle cell disease

Design outcomes

Primary

Measure	Time frame
Blood loss reduction during and after Caesarean section	—

Secondary

Measure	Time frame
Postpartum haemorrhage at Caesarean section, need for additional uretonics, need for blood transfusion , APGAR scores	—

Countries

Nigeria

Contacts

Public ContactFrancis Adebayo

Supervisor

Preciousdavis67@gmail.com+2349096728284

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026